Compendium of Cancer Genome Aberrations

HAEM5:ALK-negative anaplastic large cell lymphoma: Difference between revisions

(View all pending changes)
[pending revision][pending revision]
← Older editNewer edit →
VisualWikitext
Line 177: Line 177:
|
|
*<nowiki>*See t(6;7) notes</nowiki>
*<nowiki>*See t(6;7) notes</nowiki>
*5-year overall survival > 17%
*5-year overall survival 17%
|-
|-
|t(10;19)(q24;p13)
|t(10;19)(q24;p13)
Line 285: Line 285:
|No
|No
|
|
* Prevalence 30%
*Prevalence 30%
* Numerous genes affected
*Numerous genes affected
|-
|-
|6p
|6p
Line 296: Line 296:
|No
|No
|
|
* Prevalence 30%
*Prevalence 30%
* Gene affected: ''DUSP22''
*Gene affected: ''DUSP22''
|-
|-
|8q
|8q
Line 307: Line 307:
|No
|No
|
|
* Prevalence 16-23%
*Prevalence 16-23%
* Genes affected: NDRG1, ''PHF20L1, SLA, ST3GAL1, TG, WISP1''
*Genes affected: NDRG1, ''PHF20L1, SLA, ST3GAL1, TG, WISP1''
|-
|-
|1p
|1p
Line 319: Line 319:
|No
|No
|
|
* Prevalence 19-26%
*Prevalence 19-26%
|-
|-
|'''6q'''
|'''6q'''
Line 329: Line 329:
|No
|No
|
|
* Prevalence 35%
*Prevalence 35%
* Genes affected: '''''PRDM1''', ATG5''
*Genes affected: '''''PRDM1''', ATG5''
|-
|-
|10p
|10p
Line 340: Line 340:
|No
|No
|
|
* Prevalence 23%
*Prevalence 23%
|-
|-
|13q
|13q
Line 350: Line 350:
|No
|No
|
|
* Prevalence 23%
*Prevalence 23%
* Genes affected: ''CDC16, CUL4A,FOXO1A, BRCA2, LHFP, LCP1''
*Genes affected: ''CDC16, CUL4A,FOXO1A, BRCA2, LHFP, LCP1''
|-
|-
|16q
|16q
Line 361: Line 361:
|No
|No
|
|
* Prevalence 29%
*Prevalence 29%
* Genes affected: ''MAF, WWOX''
*Genes affected: ''MAF, WWOX''
|-
|-
|17p
|17p
Line 372: Line 372:
|No
|No
|
|
* Prevalence: 42%
*Prevalence: 42%
* ''Gene affected: TP53''
*''Gene affected: TP53''
|}
|}


Retrieved from "https://test.ccga.io/index.php/HAEM5:ALK-negative_anaplastic_large_cell_lymphoma"